Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
63
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
SBI Cards & Payment Services
•
12 May 2024 06:05
Quiddity Leaderboard NIFTY Sep 24: Strong Flow Rationale for LONG Jio Financial - SHORT SBI Cards
SBI Cards is an expected DEL for NIFTY Next 50 in Sep 24 and BSE 100 in Jun 24. Jio Financial is an expected ADD for both BSE 100 and BSE 200 in...
Janaghan Jeyakumar, CFA
Follow
406 Views
Share
bearish
•
LTIMindtree
•
15 Apr 2024 20:23
Quiddity Leaderboard NIFTY Sep 24: Multiple Names Eligible for NIFTY 50 Addition
For NIFTY 50, the top-ranked potential ADD and DEL are Trent Ltd and LTIMindtree respectively. I expect there to be at least one NIFTY 50 change in...
Janaghan Jeyakumar, CFA
Follow
363 Views
Share
bullish
•
Gland Pharma Ltd
•
08 Apr 2024 21:43
Gland Pharma Ltd (GLAND IN): Business Recovery Seems To Be Overlooked by Mr. Market
Gland Pharma reports steady growth in base business and is confident to end FY24 on high note. While the US will remain main growth driver, the...
Tina Banerjee
Follow
321 Views
Share
bullish
•
Bharat Electronics
•
23 Jan 2024 17:59
Quiddity Leaderboard NIFTY Mar 24: Bharat Electronics Trade Successful; Change Hedge and Let It Run
The reference period for the NIFTY 50 & NIFTY Next 50 March 2024 rebalance ends on 31st January 2024. There are no changes to my index changes...
Janaghan Jeyakumar, CFA
Follow
791 Views
Share
bullish
•
Petroleo Brasileiro
•
06 Jan 2024 03:50
Buys Within Global Energy, Health Care, and Utilities; Bullish Outlook Intact on Global Equities
Seeing a clear shift into value and defensives, and we recommend adding exposure to these areas globally. Constructive if supports hold: $98-99 on...
Vermilion Research
Follow
439 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x